India’s Zydus Life reports inflation in second-quarter profit on steady U.S. demand
Nov 12 (Reuters) – Indian drugmaker Zydus Lifesciences (ZYDU.NS), opens new tabon Tuesday reported a 14% rose in second-quarter profit, helped by strong demand for generic drugs in its key United States and Indian markets.The company’s consolidated net profit rose to 9.11 billion rupees ($107.93 million), in line with analysts’ average estimate of 9.13 billion…